SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Size: px
Start display at page:

Download "SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL"

Transcription

1 SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation of common symptoms that are known to cause distress at this time. Doses suggested in the Palliative Care order set are for guidance only; if a patient is already on opiates or sedatives, different dosing regimes may be appropriate. Please contact the Hospital Palliative Care Team if you require further advice. For further information regarding prescribing at the end of life, please refer to the Derbyshire Handbook of Priorities for Care, available within the Derbyshire End of Life Toolkit (via Toolkit link on FLO). For more detailed information regarding specific symptoms at the end of life, please refer to the following: Nausea and vomiting Constipation Agitation Breathlessness Approximate opiate dose conversions Syringe driver combinations available at DHFT (November 2014) For more information about treating diabetes in patients who are believed to be dying please refer to the following:

2 Assess for possible causes, for example: Nausea & Vomiting Drug induced, chemo, NSAIDs, antibiotics Gastric outlet obstruction, large volume vomits Constipation Intestinal obstruction, distended abdomen, colicky abdominal pain Infection Metabolic, hypercalcaemia, renal failure Raised intracranial pressure Anxiety Treat the cause if appropriate. Indication Drug Oral dose Subcutaneous Also consider.. infusion/24hrs Drug induced Haloperidol 0.5 3mg od 3 5mg Stop offending drug, PPI Gastric outlet obstruction Metoclopramide 10mg tds 30 75mg Obstruction without colic Domperidone 10mg tds Metoclopramide 10mg tds 30 75mg Dexamethasone Obstruction with colic Cyclizine +/- Haloperidol +/- 50mg tds 1.5 3mg od 150mg 3 5mg Dexamethasone Metabolic Hyoscine Haloperidol 20mg tds 1.5 3mg od mg 3 5mg Raised Intracranial pressure Levomepromazine mg mg Cyclizine 50mg tds 150mg Dexamethasone If unable to tolerate oral medication can give medication as SC PRNs (EXCEPT Domperidone)

3 Constipation Prevention better than cure! Think laxative when prescribing opioids Oral laxatives (doses divided per day according to response) Maximise dose of laxative before switching to an alternative Drug Starting dose Maintenance Maximum dose dose Stimulants Senna (tablets or liquid) 7.5mg mg mg or Bisocodyl 5 mg 5-10mg 20mg plus Softeners Docusate 100mg mg 500mg or Lactulose 10ml 20 40ml 30-60ml or Movicol/Laxido 1 sachet 1 3 sachets 8 sachets in faecal impaction Rectal intervention based on PR examination Rectal findings Agent Reason Soft faeces Firm faeces Hard faeces Microlax enema or Bisacodyl suppository Glycerine suppository followed by Bisacodyl suppository or microlax enema 2 Glycerine suppositories left in for 1 hour then phosphate enema Stimulate evacuation Soften then stimulate Soften then stimulate

4 Assess for possible causes, for example: Urinary retention Faecal impaction Increased pain Infection Hypoxia Treat the cause if appropriate. Agitation Indication Drug Dose Drug toxicity Metabolic upset Altered sensorium Hallucinations Haloperidol PO 1-5 3mg SC 1 5mg bolus CSCI mg / 24hrs Anxiety & Distress Risk of seizure Alternative or additional sedation Nausea Altered sensorium and anxiety Midazolam Levomepromazine Combine Haloperidol and Midazolam SC mg bolus CSCI mg / 24hrs PO mg up to qds SC mg bolus 4 hourly CSCI mg / 24hrs

5 Assess for possible causes, for example: Infection COPD PE Superior vena caval obstruction Pleural effusion Ascites Anaemia Cardiac failure Anxiety Treat the cause if appropriate. Breathlessness Morphine If opioid naïve, oramorph 2.5 5mg four hourly If on opioids, increase the dose of opioid Terminal breathlessness, if opioid naïve, cscidiamorphine 5 10mg/24hours or convert existing morphine dose to diamorphine Benzodiazepines if there is an element of anxiety and panic to breathlessness Diazepam 2mg bd increasing to 5mg bd Lorazepam 0.5 1mg used sublingually for panic attacks/acute breathlessness Midazolam 2.5 5mg PRN sc or 5 10mg csci/24hours Also consider position of patient, fan, relaxation

6 Approximate dose conversions ratios: PO to PO Opiate dose conversions Conversion and Ratio Calculation Example Codeine PO to morphine PO 10:1 Divide 24h codeine dose by 10 Codeine 240mg/24h PO morphine 24mg/24h PO Tramadol PO to morphine PO 10:1 Divide 24h tramadol dose by 10 Tramadol 400mg/24h PO morphine 40 mg/24h PO Morphine PO to oxycodone PO 2:1 Divide 24h morphine dose by 2 Morphine 30mg/24h PO oxycodone 15mg/24h PO Approximate dose conversions ratios: PO to SC Conversion and Ratio Calculation Example Morphine PO to diamorphine SC 3:1 Divide 24h morphine dose by 3 Morphine 30mg/24h PO diamorphine 10mg/24h SC Morphine PO to morphine SC 2:1 Divide 24h morphine dose by 2 Morphine 30mg/24h PO 15mg/24h SC Oxycodone PO to oxycodone SC 2:1 Divide 24h oxycodone dose by 2 Oxycodone 30mg/24h PO oxycodone 15mg/24h SC Fentanyl and buprenorphine transdermal (TD) patches Patches are contraindicated in patients with acute pain which requires rapid titration. An analgesic effect may take > 12h. Patients on patches will still require p.r.n. medication. See table below: Morphine PO MorphineSC DiamorphineSC Fentanyl patch (3 day patch) mg/24h p.r.n. mg mg/24h p.r.n. mg mg/24h p.r.n. mg microgram/h a a. for combinations of Fentanyl patches, add the p.r.n. doses together, e.g microgram/h patches = mg morphine SC = 35mg morphine SC, but can round up to 40mg or down to 30mg for convenience. Comparative doses of morphine/diamorphine and TD buprenorphine (based on PO morphine: TD buprenorphine dose ratio 100:1) Morphine PO MorphineSC DiamorphineSC Buprenorphine patch mg/24h p.r.n. mg mg/24h p.r.n. mg mg/24h p.r.n. mg Microgram/h BuTrans(7 day patch) 12 2 a a Transtec(4 day patch) b a. at these doses, p.r.n. codeine (30-60mg) or tramadol (50mg) may suffice. b. for combinations of patches, add the p.r.n. doses together, e.g microgram/h patches = mg morphine SC = 25mg morphine SC but can round up to 30 mg or down to 20mg for convenience.

7 All syringes are made up to 15ml Syringe Driver Combinations Single drug DRUG EXPIRY STORAGE LIMITS Cyclizine 7 days Diamorphine days if prepared in a licensed unit Haloperidol 7 days Hyoscine 7 days Levomepromazine 7 days Metoclopramide 3 days Fridge Max 75mg in 15ml Midazolam 7 days Octreotide 4 days Fridge Oxycodone 7 days 15mg to 150mg in 15ml 2 Drug combinations Cyclizine + Haloperidol 24 hrs Cyclizine max 150mg Haloperidol 4.5mg Diamorphine + Cyclizine 24 hrs/ 7 days Cyclizine max 100mg with Diamorphine 301mg-1.5g (7d) Cyclizine max 150mg with Diamorphine up to 150mg (7d) Cyclizine max 150mg with Diamorphine mg (24hrs) Diamorphine + Haloperidol 24 hrs/ 7 days Haloperidol max 10mg with Diamorphine up to 1.5g (7d) Haloperidol max 10mg with Diamorphine up to 2g (24hrs) Diamorphine + Hyoscine Diamorphine + Levomepromazine 7 days 7 days Protect from light until administered to patients Diamorphine + Metoclopramide 72hrs Fridge Diamorphine + Midazolam 7 days Midazolam max 75mg with Diamorphine up to 500mg

8 Diamorphine + Octreotide 96hrs Fridge Haloperidol + Hyoscine 24hrs Haloperidol + Midazolam 24hrs Haloperidol max 7.5mg with Midazolam up to 60mg Levomepromazine + Hyoscine 24hrs Protect from light until administered to patients Midazolam + Hyoscine 24hrs Midazolam + Octreotide 24hrs Oxycodone + Cyclizine 24hrs Cyclizine max 45mg with Oxycodone mg Oxycodone + Haloperidol 24hrs Haloperidol up to 7.5mg with Oxycodone mg Oxycodone + Hyoscine butylbromide Oxycodone + Levomepromazine 24hrs Hyoscine butylbromide up to 35mg with Oxycodone mg 24hrs Levomepromazine mg with Oxycodone mg. Protect from light until administered to patient Oxycodone + Metoclopramide 24hrs Metoclopramide up to 35mg with Oxycodone mg Oxycodone + Midazolam 24hrs Midazolam up to 35mg with Oxycodone mg 3 Drug Combinations Diamorphine + Cyclizine + Haloperidol Diamorphine + Haloperidol + Hyoscine Diamorphine + Haloperidol + Midazolam Diamorphine + Hyoscine + Levomepromazine 24hrs Diamorphine up to 750mg Cyclizine up to 150mg Haloperidol up to 20mg 24hrs 24hrs Diamorphine up to 1g Haloperidol up to 7.5mg Midazolam up to 60mg 24hrs Protect from light until administered to patient Diamorphine + Hyoscine + Midazolam Diamorphine + Midazolam + Octreotide 24hrs 24hrs

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of

More information

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive. PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,

More information

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PAIN MANAGEMENT Patient established on oral morphine or opioid naive. PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

Palliative Care. Pocketbook 4

Palliative Care. Pocketbook 4 Nottinghamshire STP EOL Programme Board 2019 Review 2022 Palliative Care Pocketbook 4 Contents Pain Guidelines page 2 Nausea and Vomiting page 9 Inoperable Bowel Obstruction page 10 Constipation page 11

More information

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017

More information

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice. Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative

More information

End of life prescribing guidance

End of life prescribing guidance End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly

More information

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon Symptom Control in the Community Setting Dr Andrew Tysoe-Calnon Lead Consultant t Common symptoms Pain Agitation Shortness of breath Nausea and vomiting Intestinal obstruction Confusion Pain Occurs in

More information

Syringe driver in Palliative Care

Syringe driver in Palliative Care Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24

More information

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A

More information

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117

More information

Supportive Care. End of Life Phase

Supportive Care. End of Life Phase Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of

More information

SYRINGE DRIVER MEDICATIONS

SYRINGE DRIVER MEDICATIONS SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015 Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil

More information

Renal Palliative Care Last Days of Life

Renal Palliative Care Last Days of Life Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr

More information

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients

More information

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients

More information

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti- Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the

More information

Palliative Care Formulary

Palliative Care Formulary Palliative Care Formulary 2016-2019 This formulary for pain and symptom management in adults is intended as a guide for prescribers in hospital and community. Special care should be taken when prescribing

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

Palliative Prescribing - Pain

Palliative Prescribing - Pain Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing

More information

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure. Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients

More information

Care in the Last Days of Life

Care in the Last Days of Life Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient

More information

What s New 2003? What new treatments? What have you discontinued? More information please!

What s New 2003? What new treatments? What have you discontinued? More information please! What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?

More information

Palliative care for heart failure patients. Susan Addie

Palliative care for heart failure patients. Susan Addie Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

Algorithms for Symptom Management. In End of Life Care

Algorithms for Symptom Management. In End of Life Care Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the

More information

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30) GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be

More information

Symptom Management Guidelines for End of Life Care

Symptom Management Guidelines for End of Life Care Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can

More information

Conservative Management of Uraemia

Conservative Management of Uraemia Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early recognition of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30 If more information is required please seek help from specialist palliative care pioid dose conversion chart, syringe driver doses, rescue/prn doses and opioid patches Use the conversion chart to work

More information

BREATHLESSNESS MANAGEMENT

BREATHLESSNESS MANAGEMENT Guideline Name: Breathlessness BACKGROUND Breathlessness is a common symptom in patients with cancer, end-stage heart failure and end-stage chronic obstructive pulmonary disease (COPD). There are many

More information

End Stage Liver Disease Regional Audit Casenote Survey

End Stage Liver Disease Regional Audit Casenote Survey 1. This questionnaire is an audit of clinical documentation of patients who have died of end stage liver disease. If you have any questions about how this form should be completed please contact Dr Grace

More information

PRIMARY CARE PALLIATIVE CARE FORMULARY

PRIMARY CARE PALLIATIVE CARE FORMULARY PRIMARY CARE PALLIATIVE CARE FORMULARY This formulary has been developed between West Essex CCG and the palliative care team at St Clare Hospice. The aim of the formulary is to ensure that medicines use

More information

Using syringe pumps in palliative care

Using syringe pumps in palliative care Using syringe pumps in palliative care Facilitator: Barbara Stone RN Ground rules Medication matching game Learning outcomes To identify the indications for using a syringe pump To discuss the general

More information

PRIMARY CARE PALLIATIVE CARE FORMULARY

PRIMARY CARE PALLIATIVE CARE FORMULARY PRIMARY CARE PALLIATIVE CARE FORMULARY National Institute for Health and Care Excellence (NICE) guidance NG31 (Care of dying adults in the last days of life) supports the need to prescribe anticipatory

More information

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved

More information

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice Essential Syringe Driver Training for T 34 Elaine Bird St Luke s Hospice Aim For all practitioners to be accountable for their individual competence and capability when caring for a resident with a T34

More information

Lothian Palliative Care Guidelines POCKET EDITION 2004

Lothian Palliative Care Guidelines POCKET EDITION 2004 Lothian Palliative Care Guidelines POCKET EDITION 2004 These guidelines have been developed by a multidisciplinary group of specialist and non-specialist health professionals from hospital, community and

More information

Bulletin Independent prescribing information for NHS Wales

Bulletin Independent prescribing information for NHS Wales Bulletin Independent prescribing information for NHS Wales Palliative care pain and symptom control February 2017 Palliative care is defined by the World Health Organisation (WHO) as, An approach that

More information

Palliative Care Impact Survey

Palliative Care Impact Survey September 2018 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the

More information

This survey aims to look at individual practice and can be completed by any healthcare professional.

This survey aims to look at individual practice and can be completed by any healthcare professional. This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting (ghlting@doctors.net.uk)

More information

Clatterbridge Centre for Oncology

Clatterbridge Centre for Oncology Clatterbridge Centre for Oncology CONTENTS 1. Why and when to use a syringe driver 2. Siting the syringe driver 3. Mixing and measuring 4. Setting up the syringe driver 5. Drug information 6. Common problems

More information

AMBER Prescribing should only be undertaken in General Practice under the advice of the local hospice or specialist palliative care team.

AMBER Prescribing should only be undertaken in General Practice under the advice of the local hospice or specialist palliative care team. PRIMARY CARE PALLIATIVE CARE FORMULARY This formulary has been developed between West Essex CCG and the palliative care team at St Clare Hospice. The aim of the formulary is to ensure that medicines use

More information

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven Bradford, Airedale, Wharfedale & Craven Managed Clinical Network SYMPTOM CONTROL IN THE LAST DAYS OF LIFE Guidelines for Healthcare Professionals Bradford, Airedale, Wharfedale & Craven Signs and symptoms

More information

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett Anticipatory prescribing and end of life considerations Dr Stephanie Lippett contents Pain Restlessness/agitation Nausea/vomiting Secretions Syringe driver Anticipatory prescribing Important things to

More information

BJF Acute Pain Team Formulary Group

BJF Acute Pain Team Formulary Group Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution

More information

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Originally produced: July 2006 First Review: August 2009 Second Review: November 2011 For review November 2013 Approved

More information

Care of dying adults in the last days of life. Improving care at the very end of life.

Care of dying adults in the last days of life. Improving care at the very end of life. Care of dying adults in the last days of life Improving care at the very end of life. Foreword We will all experience death, whether it is our own or that of a loved one. The bereaved person s perception

More information

Berkshire West Area Prescribing Committee Guidance

Berkshire West Area Prescribing Committee Guidance Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for

More information

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] [Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose

More information

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER

More information

Enhanced Community Palliative Support Services. Lynne Ghasemi St Luke s Hospice

Enhanced Community Palliative Support Services. Lynne Ghasemi St Luke s Hospice Enhanced Community Palliative Support Services Lynne Ghasemi St Luke s Hospice Learning Outcomes Define the different types of pain Describe the process of pain assessment Discuss pharmacological management

More information

Managing dying with chronic heart failure

Managing dying with chronic heart failure Heart failure Managing dying with chronic heart failure Chronic heart failure (CHF) is predominantly a pathology of old age affecting 5% of those over 75 years of age. It is more common than cancer and

More information

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents: Palliative Care Out-of-hours. A resource pack for West Dorset Contents: Section 1 Supply of drugs DCH Pharmacy hours and arrangements How to contact a community pharmacist out of hours Palliative care

More information

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital. Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital. Things to consider: 1. Very common symptoms. 2. Can occur in any

More information

Coversheet for Network Site Specific Group Agreed Documentation

Coversheet for Network Site Specific Group Agreed Documentation Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance

More information

East Kent Prescribing Group

East Kent Prescribing Group East Kent Prescribing Group Symptom Control and Care of the Dying Patient: Palliative Care Guidelines 5th Edition Approved by the East Kent Prescribing Group. Approved by: East Kent Prescribing Group (Representing

More information

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017 Pain management in Paediatric Palliative Care Dr Jane Nakawesi 14 th August 2017 Content Management of pain in children Non pharmacological Pharmacological Exit level outcomes The participants will: Know

More information

Greater Manchester & Cheshire Cancer Network

Greater Manchester & Cheshire Cancer Network Fifth Version Palliative Care Salford Pain and Symptom Control Guidelines Greater Manchester & Cheshire Cancer Network Publication Date: April 2009: Review Date: April 2011 Symtpom Control Guidance Final

More information

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number: FILE IN PATIENT S COMMUNITY HEALTH RECORD FOLDER : SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRERIPTION & ADMINISTRATION RECORD (SPAR) Abbreviations used in this document to be listed here with the full

More information

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan Pain management in palliative care Dr. Stepanie Lippett and Sister Karen Davies-Linihan contents Concept of total pain Steps in pain management Recognising neuropathic pain WHO analgesic ladder Common

More information

PALLIATIVE CARE SYMPTOM CONTROL GUIDELINES. Adapted from: Greater Manchester Strategic Clinical Network Guidelines

PALLIATIVE CARE SYMPTOM CONTROL GUIDELINES. Adapted from: Greater Manchester Strategic Clinical Network Guidelines PALLIATIVE CARE SYMPTOM CONTROL GUIDELINES Adapted from: Greater Manchester Strategic Clinical Network Guidelines 1 PALLIATIVE CARE SYMPTOM CONTROL GUIDELINES NOTES Many drugs are used in palliative care

More information

Regional Renal Training

Regional Renal Training Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing

More information

Symptom Control in Heart Failure. Dr Claire L Hookey

Symptom Control in Heart Failure. Dr Claire L Hookey Symptom Control in Heart Failure Dr Claire L Hookey Heart Failure symptoms Class III/IV CHF, mean 67.1 years, mean EF 22.3% Most prevalent symptoms:- lack of energy (66%) dry mouth (62%) shortness of breath

More information

Clinical Practice Summary

Clinical Practice Summary Lancashire Medicines Management Group North West Coast Strategic Clinical Networks Clinical Practice Summary Guidance on consensus approaches to managing Palliative Care Symptoms Lancashire and South Cumbria

More information

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:

More information

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.

More information

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) May 2018 THE WATERLOO WELLINGTON SYMPTOM MANAGEMENT GUIDELINE FOR THE END OF

More information

Planning for the future; A guide to symptom control at end of life in advanced dementia

Planning for the future; A guide to symptom control at end of life in advanced dementia Planning for the future; A guide to symptom control at end of life in advanced dementia Item Type Guideline Authors Irish Hospice Foundation;St Vincent's Hospital, Athy;St Brigid's Hospice Publisher Irish

More information

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. The closing date for responses is 19th December The results

More information

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP). Surrey (East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG & Surrey Heath CCG) North East Hampshire & Farnham CCG and Crawley, Horsham & Mid-Sussex CCG Guidelines for the

More information

Eastern Health and Social Services Board Palliative Care

Eastern Health and Social Services Board Palliative Care Eastern Health and Social Services Board Palliative Care Out of Hours Symptom advice leaflets Adult Palliative care patients (Compiled by Macmillan GP Facilitators March 2008) 1 CONTENTS PAIN Control of

More information

The last days of life in hospital and at home

The last days of life in hospital and at home The last days of life in hospital and at home Beaumont Multi-disciplinary Palliative Care Study Day 28/9/2017 Dr Sarah McLean Consultant in Palliative Medicine St Francis Hospice Beaumont Hospital Overview

More information

A Guide to Symptom Management in Palliative Care

A Guide to Symptom Management in Palliative Care A Guide to Symptom Management in Palliative Care Supported by Health Education England Version 6.1 Publication date: June 2016 Review date: June 2019 1 2 Yorkshire and Humber Palliative and End of Life

More information

West Midlands Palliative Care Physicians. Palliative care. Guidelines for the use of drugs in symptom control

West Midlands Palliative Care Physicians. Palliative care. Guidelines for the use of drugs in symptom control West Midlands Palliative Care Physicians Palliative care Guidelines for the use of drugs in symptom control Revised Jan 2012 1 5th Edition, 2012 Guidelines for the use of drugs in symptom control These

More information

survey Parenteral anti-epileptics What is your experience? May July 2015

survey Parenteral anti-epileptics What is your experience? May July 2015 Parenteral anti-epileptics What is your experience? May July 2015 Number of responses = 99 1a) In patients with pre-existing epilepsy controlled by PO medication that are imminently dying (prognosis

More information

PALLIATIVE CARE PRESCRIBING

PALLIATIVE CARE PRESCRIBING PALLIATIVE CARE PRESCRIBING LANCASHIRE AND SOUTH CUMBRIA SPECIALIST PALLIATIVE CARE SERVICES 2010 Refer to electronic verson site for latest information. Review Date September 2011 NAVIGATIONAL INSTRUCTIONS

More information

Implementing the recommendation on medication management and symptom control

Implementing the recommendation on medication management and symptom control Implementing the recommendation on medication management and symptom control Mike Grocott Professor of Anaesthesia and Critical Care Medicine University of Southampton Consultant in Critical Care Medicine

More information

Managing Care at End of Life:

Managing Care at End of Life: Managing Care at End of Life: Physical Suffering Pain & Dyspnea Verna Sellers, MD, MPH, AGSF Medical Director Centra PACE Lynchburg, Virginia 1 Speaker Disclosures: Dr. Sellers has disclosed that she has

More information

Clinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults

Clinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults Clinical Guideline Guidelines for the use of opioid analgesics in the management of acute pain in adults Document detail Document location West Kent and MTW Formulary Version 1.0 Effective from July 2017

More information

PALLIATIVE CARE PRESCRIBING

PALLIATIVE CARE PRESCRIBING PALLIATIVE CARE PRESCRIBING LANCASHIRE AND SOUTH CUMBRIA SPECIALIST PALLIATIVE CARE SERVICES 2012 Refer to electronic verson at www.cancerlancashire.org.uk for latest information. Review Date January 2014

More information

Health Learning Partnership End of Life Care 29 th June 2016

Health Learning Partnership End of Life Care 29 th June 2016 Health Learning Partnership End of Life Care 29 th June 2016 Beth Wright Consultant in Palliative Medicine Case 1 Malignant bowel obstruction Sarah is a 43 year old woman colon cancer, diagnosed in 2014.

More information

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110 Berkshire Adult Palliative Care Guidelines - End of Life Care GL110 Approval Approval Group Job Title, Chair of Committee Date Drugs & Therapeutic Committee Chair, Drugs & Therapeutic Committee October

More information

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2. Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.

More information

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1.1 GENERAL PRINCIPLES There are many causes of agitation in palliative care patients, which makes recommendations for treatment difficult.

More information

Yorkshire Cancer Network

Yorkshire Cancer Network Yorkshire Cancer Network and Humber & Yorkshire Coast Cancer Network A GUIDE TO SYMPTOM MANAGEMENT IN PALLIATIVE CARE Publication date: June 2009 Review date: May 2011 YORKSHIRE CANCER NETWORK PALLIATIVE

More information

Palliative Emergencies. Ken Stakiw

Palliative Emergencies. Ken Stakiw Palliative Emergencies Ken Stakiw Disclosure None to disclose for this lecture Have received honoraria from a number of agencies and companies previously Intend to discuss some off label use of medications

More information

Pain. Christine Illingworth. Community Nurse St Luke s Hospice 17/5/17

Pain. Christine Illingworth. Community Nurse St Luke s Hospice 17/5/17 Pain Christine Illingworth Community Nurse St Luke s Hospice 17/5/17 What is pain? Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage Pain is whatever

More information

Pain Management Strategies Webinar/Teleconference

Pain Management Strategies Webinar/Teleconference Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits

More information

Approach to symptom control near the end-of-life

Approach to symptom control near the end-of-life Approach to symptom control near the end-of-life 18 Sept 2011 Dr Alethea Yee Senior Consultant, Department of Palliative Medicine National Cancer Centre,Singapore What is end of life? No precise definition

More information

Palliative Patient in Emergency Department

Palliative Patient in Emergency Department Palliative Patient in Emergency Department Dr Thiru Thirukkumaran Palliative Care Services NW THO Northwest Regional Hospital, Burnie Northwest Tasmania Outline the Session Introduction What is palliative

More information

Palliative Care Emergencies. Additional module if needed

Palliative Care Emergencies. Additional module if needed Palliative Care Emergencies Additional module if needed Learning objectives Understand emergency /urgent / important Describe common emergencies in PC Explore principles of essential management Outline

More information

Adult Opioid Prescribing Guidelines for Acute or Persistent Pain

Adult Opioid Prescribing Guidelines for Acute or Persistent Pain Adult Opioid Prescribing Guidelines for Acute or Persistent Pain Author: Sponsor/Executive: Responsible committee: Consultation & Approval: (Committee/Groups which signed off the policy, including date)

More information

Understanding pain in 5 minutes

Understanding pain in 5 minutes Pain Management- PallCare Definition of Pain Pain is what the patient says hurts. Dr Simon Allan Director of Palliative Care Arohanui Hospice An unpleasant sensory and emotional experience associated with

More information